| 0078-0607 | These highlights do not include all the information needed to use GILENYA ® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 | Novartis Pharmaceuticals Corporation |
| 0078-0607-15 | These highlights do not include all the information needed to use GILENYA ® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 | Novartis Pharmaceuticals Corporation |
| 0078-0607-51 | These highlights do not include all the information needed to use GILENYA ® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 | Novartis Pharmaceuticals Corporation |
| 0078-0607-89 | These highlights do not include all the information needed to use GILENYA ® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 | Novartis Pharmaceuticals Corporation |
| 0078-0965 | These highlights do not include all the information needed to use GILENYA ® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 | Novartis Pharmaceuticals Corporation |
| 0078-0965-89 | These highlights do not include all the information needed to use GILENYA ® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 | Novartis Pharmaceuticals Corporation |
| 0378-4525 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Mylan Pharmaceuticals Inc. |
| 0378-4525-93 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Mylan Pharmaceuticals Inc. |
| 0480-7820 | FINGOLIMOD These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. Initial U.S. Approval: 2010 | AvKARE |
| 0480-7820 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Teva Pharmaceuticals, Inc. |
| 0480-7820-56 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Teva Pharmaceuticals, Inc. |
| 16729-342 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 16729-342-10 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 16729-342-15 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 16729-342-17 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 16729-342-87 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 16729-342-88 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 16729-342-89 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited |
| 31722-889 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | Evaric Pharmaceuticals Inc |
| 31722-889-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | Evaric Pharmaceuticals Inc |
| 42291-048 | FINGOLIMOD These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. Initial U.S. Approval: 2010 | AvKARE |
| 42291-048-30 | FINGOLIMOD These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. Initial U.S. Approval: 2010 | AvKARE |
| 43547-003 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Solco Healthcare US, LLC | Prinston Pharmaceutical Inc. | Zhejiang Huahai Pharmaceutical Co., LTD |
| 43547-003-03 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Solco Healthcare US, LLC | Prinston Pharmaceutical Inc. | Zhejiang Huahai Pharmaceutical Co., LTD |
| 43547-003-09 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Solco Healthcare US, LLC | Prinston Pharmaceutical Inc. | Zhejiang Huahai Pharmaceutical Co., LTD |
| 43598-285 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Dr. Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited FTO-7 |
| 43598-285-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Dr. Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited FTO-7 |
| 43598-285-31 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Dr. Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited FTO-7 |
| 43598-285-70 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Dr. Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited FTO-7 |
| 43598-285-79 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES . FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Dr. Reddy's Laboratories Inc | Dr.Reddy's Laboratories Limited FTO-7 |
| 46708-228 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Alembic Pharmaceuticals Limited |
| 46708-228-10 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Alembic Pharmaceuticals Limited |
| 46708-228-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Alembic Pharmaceuticals Limited |
| 60505-4332 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Apotex Corp. |
| 60505-4332-1 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Apotex Corp. |
| 60505-4332-3 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Apotex Corp. |
| 62332-228 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited |
| 62332-228-10 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited |
| 62332-228-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited |
| 62756-064 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 62756-064-59 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 62756-064-81 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 62756-064-83 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 62756-064-96 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 64980-449 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Rising Pharma Holdings, Inc. | Sunshine Lake Pharma Co., Ltd. |
| 64980-449-03 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Rising Pharma Holdings, Inc. | Sunshine Lake Pharma Co., Ltd. |
| 64980-449-07 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Rising Pharma Holdings, Inc. | Sunshine Lake Pharma Co., Ltd. |
| 64980-449-28 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Rising Pharma Holdings, Inc. | Sunshine Lake Pharma Co., Ltd. |
| 64980-449-97 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Rising Pharma Holdings, Inc. | Sunshine Lake Pharma Co., Ltd. |
| 65862-952 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Aurobindo Pharma Limited |
| 65862-952-07 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Aurobindo Pharma Limited |
| 65862-952-28 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Aurobindo Pharma Limited |
| 65862-952-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Aurobindo Pharma Limited |
| 67877-476 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 67877-476-14 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 67877-476-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 67877-476-32 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 67877-476-33 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 67877-476-56 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 67877-476-58 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Ascend Laboratories, LLC | Alkem Laboratories Limited |
| 68382-912 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-912-01 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-912-06 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-912-16 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-912-69 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-912-70 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68462-166 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Skya Health, LLC |
| 68462-166 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 68462-166-07 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 68462-166-15 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 68462-166-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 68462-166-41 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 70377-019 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Biocon Pharma Inc. | Biocon Limited | Biocon Pharma Limited |
| 70377-019-11 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Biocon Pharma Inc. | Biocon Limited | Biocon Pharma Limited |
| 70377-019-21 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Biocon Pharma Inc. | Biocon Limited | Biocon Pharma Limited |
| 70709-062 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent Pharma Solutions |
| 70709-062 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent U.K. Swindon Zydis Limited |
| 70709-062-30 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent Pharma Solutions |
| 70709-062-30 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent U.K. Swindon Zydis Limited |
| 70709-065 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent U.K. Swindon Zydis Limited |
| 70709-065 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent Pharma Solutions |
| 70709-065-30 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent U.K. Swindon Zydis Limited |
| 70709-065-30 | These highlights do not include all the information needed to use TASCENSO ODT ® safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010 | Cycle Pharmaceuticals Ltd | Catalent Pharma Solutions |
| 70771-1603 | Fingolimod Capsules | Zydus Lifesciences Limited |
| 70771-1603-1 | Fingolimod Capsules | Zydus Lifesciences Limited |
| 70771-1603-3 | Fingolimod Capsules | Zydus Lifesciences Limited |
| 70771-1603-7 | Fingolimod Capsules | Zydus Lifesciences Limited |
| 70771-1603-8 | Fingolimod Capsules | Zydus Lifesciences Limited |
| 70771-1603-9 | Fingolimod Capsules | Zydus Lifesciences Limited |
| 72865-257 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | XLCare Pharmaceuticals Inc. | Evaric Pharmaceuticals Inc |
| 72865-257-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | XLCare Pharmaceuticals Inc. | Evaric Pharmaceuticals Inc |
| 73086-300 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Skya Health, LLC |
| 73086-300-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Skya Health, LLC |
| 82009-143 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Quallent Pharmaceuticals Health LLC | Biocon Limited | Biocon Pharma Limited |
| 82009-143-30 | These highlights do not include all the information needed to use FINGOLIMOD CAPSULES safely and effectively. See full prescribing information for FINGOLIMOD CAPSULES. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | Quallent Pharmaceuticals Health LLC | Biocon Limited | Biocon Pharma Limited |
| 82249-385 | These highlights do not include all the information needed to use FINGOLIMOD safely and effectively. See full prescribing information for FINGOLIMOD. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | CivicaScript LLC | Alkem Laboratories Limited |
| 82249-385-30 | These highlights do not include all the information needed to use FINGOLIMOD safely and effectively. See full prescribing information for FINGOLIMOD. FINGOLIMOD capsules, for oral use Initial U.S. Approval: 2010 | CivicaScript LLC | Alkem Laboratories Limited |